Literature DB >> 9678287

Changes in total and high-density lipoprotein cholesterol over 10- and 20-year periods (the Honolulu Heart Program).

R D Abbott1, K Yano, A A Hakim, C M Burchfiel, D S Sharp, B L Rodriguez, J D Curb.   

Abstract

Limited data are available on patterns of change in lipids and lipoproteins as persons age. The purpose of this report is to describe the 10-year change in total and high-density lipoprotein (HDL) cholesterol according to suspected determinants in 898 Japanese-American men enrolled in the Honolulu Heart Program. Data are based on examinations that occurred from 1970 to 1972 and at repeat examinations received 10 and 20 years later. At the last examination, men were aged 71 to 93 years. Mean reductions in total cholesterol in the second 10 years of follow-up (24 mg/dl) were more than double the reductions observed in the first 10 years (9 mg/dl). Levels of total cholesterol declined and levels of HDL cholesterol increased regardless of beginning levels of systolic blood pressure, body mass index, physical activity, cigarette smoking status, or the use of treatment for hypertension or elevated total cholesterol. Men with prevalent coronary heart disease experienced greater reductions (p <0.05) in total cholesterol during the second 10 years of follow-up (32 mg/dl) versus men without coronary heart disease (22 mg/dl). Adjustment for baseline covariates failed to alter these findings appreciably. We conclude that alterations in total and HDL cholesterol with advancing age may be expected to occur regardless of risk factor status, disease prevalence, or pharmacologic intervention. In the presence of such effects, evaluation of treatment programs to alter levels of total and HDL cholesterol in older persons should consider the possibility that even in the absence of intervention, changes could also occur due to aging alone.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9678287     DOI: 10.1016/s0002-9149(98)00310-5

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  14 in total

1.  Apolipoprotein E-related all-cause mortality in hospitalized elderly patients.

Authors:  Maria G Matera; Daniele Sancarlo; Francesco Panza; Carolina Gravina; Grazia D'Onofrio; Vincenza Frisardi; Grazia Longo; Luigi P D'Ambrosio; Filomena Addante; Massimiliano Copetti; Vincenzo Solfrizzi; Davide Seripa; Alberto Pilotto
Journal:  Age (Dordr)       Date:  2010-04-20

2.  Serum total cholesterol levels and all-cause mortality in a home-dwelling elderly population: a six-year follow-up.

Authors:  Päivi Tuikkala; Sirpa Hartikainen; Maarit J Korhonen; Piia Lavikainen; Raimo Kettunen; Raimo Sulkava; Hannes Enlund
Journal:  Scand J Prim Health Care       Date:  2010-06       Impact factor: 2.581

3.  A Metabolite Composite Score Attenuated a Substantial Portion of the Higher Mortality Risk Associated With Frailty Among Community-Dwelling Older Adults.

Authors:  Megan M Marron; Tamara B Harris; Robert M Boudreau; Clary B Clish; Steven C Moore; Rachel A Murphy; Venkatesh L Murthy; Jason L Sanders; Ravi V Shah; George C Tseng; Stacy G Wendell; Joseph M Zmuda; Anne B Newman
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2021-01-18       Impact factor: 6.053

4.  Age is positively associated with high-density lipoprotein cholesterol among African Americans in cross-sectional analysis: the Jackson Heart Study.

Authors:  Jane L Harman; Michael E Griswold; Neal O Jeffries; Anne E Sumner; Daniel F Sarpong; Ermeg L Akylbekova; Evelyn R Walker; Sharon B Wyatt; Herman A Taylor
Journal:  J Clin Lipidol       Date:  2011-03-02       Impact factor: 4.766

5.  C-reactive protein and lipid parameters in older persons aged 80 years and older.

Authors:  M Cesari; G Onder; V Zamboni; E Capoluongo; A Russo; R Bernabei; M Pahor; F Landi
Journal:  J Nutr Health Aging       Date:  2009-08       Impact factor: 4.075

6.  Impact of inflammatory biomarkers on relation of high density lipoprotein-cholesterol with incident coronary heart disease: cardiovascular Health Study.

Authors:  David M Tehrani; Julius M Gardin; David Yanez; Calvin H Hirsch; Donald M Lloyd-Jones; Phyllis K Stein; Nathan D Wong
Journal:  Atherosclerosis       Date:  2013-09-05       Impact factor: 5.162

7.  The comparative effectiveness of statin therapy in selected chronic diseases compared with the remaining population.

Authors:  Xia Sheng; Michael J Murphy; Thomas M MacDonald; Li Wei
Journal:  BMC Public Health       Date:  2012-08-30       Impact factor: 3.295

8.  Impairments in activities of daily living in older Japanese men in hawaii and Japan.

Authors:  Robert D Abbott; Aya Kadota; Katsuyuki Miura; Takehito Hayakawa; Takashi Kadowaki; Tomonori Okamura; Akira Okayama; Kamal H Masaki; Hirotsugu Ueshima
Journal:  J Aging Res       Date:  2011-06-30

9.  Secular trends in serum lipid levels of a Middle Eastern adult population; 10 years follow up in Tehran lipid and glucose study.

Authors:  Masoumeh Kheirandish; Samaneh Asgari; Mojtaba Lotfaliany; Mohammadreza Bozorgmanesh; Navid Saadat; Maryam Tohidi; Fereidoun Azizi; Farzad Hadaegh
Journal:  Lipids Health Dis       Date:  2014-01-23       Impact factor: 3.876

10.  Genome metabolome integrated network analysis to uncover connections between genetic variants and complex traits: an application to obesity.

Authors:  Beatriz Valcárcel; Timothy M D Ebbels; Antti J Kangas; Pasi Soininen; Paul Elliot; Mika Ala-Korpela; Marjo-Riitta Järvelin; Maria de Iorio
Journal:  J R Soc Interface       Date:  2014-02-26       Impact factor: 4.118

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.